APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphodiesterase-4 Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phosphodiesterase-4 Inhibitor Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchPhosphodiesterase-4 Inhibitor Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphodiesterase-4 Inhibitor Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Phosphodiesterase-4 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphodiesterase-4 Inhibitor Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphodiesterase-4 Inhibitor Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Phosphodiesterase-4 Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phosphodiesterase-4 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phosphodiesterase-4 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phosphodiesterase-4 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phosphodiesterase-4 Inhibitor include GSK, Fosun-Pharmaceutical, Amgen, AstraZeneca, Camber Pharmaceuticals and Arcutis Biotherapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phosphodiesterase-4 Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phosphodiesterase-4 Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phosphodiesterase-4 Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phosphodiesterase-4 Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phosphodiesterase-4 Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phosphodiesterase-4 Inhibitor Market by Company

GSK

Fosun-Pharmaceutical

Amgen

AstraZeneca

Camber Pharmaceuticals

Arcutis Biotherapeutics

Phosphodiesterase-4 Inhibitor Segment by Type

Oral

External Use

Phosphodiesterase-4 Inhibitor Segment by Application

Children

Adults

Phosphodiesterase-4 Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphodiesterase-4 Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphodiesterase-4 Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphodiesterase-4 Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phosphodiesterase-4 Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phosphodiesterase-4 Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of External Use Table 3. Global Phosphodiesterase-4 Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 5. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 6. Global Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 7. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type (2021-2026) Table 8. Global Phosphodiesterase-4 Inhibitor Price by Type (2021-2026) & (US$/unit) Table 9. Global Phosphodiesterase-4 Inhibitor Sales by Type (2027-2032) & (k units) Table 10. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 11. Global Phosphodiesterase-4 Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 12. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type (2027-2032) Table 13. Global Phosphodiesterase-4 Inhibitor Price by Type (2027-2032) & (US$/unit) Table 14. North America Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 15. North America Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 17. Europe Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 21. Latin America Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 24. Phosphodiesterase-4 Inhibitor Industry Trends Table 25. Phosphodiesterase-4 Inhibitor Industry Drivers Table 26. Phosphodiesterase-4 Inhibitor Industry Opportunities and Challenges Table 27. Phosphodiesterase-4 Inhibitor Industry Restraints Table 28. Global Phosphodiesterase-4 Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Company (2021-2026) Table 30. Global Phosphodiesterase-4 Inhibitor Sales by Company (2021-2026) & (k units) Table 31. Global Phosphodiesterase-4 Inhibitor Sales Share by Company (2021-2026) Table 32. Global Phosphodiesterase-4 Inhibitor Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Phosphodiesterase-4 Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Phosphodiesterase-4 Inhibitor Major Company Production Sites and Headquarters Table 35. Global Phosphodiesterase-4 Inhibitor Company, Product Type & Application Table 36. Global Phosphodiesterase-4 Inhibitor Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Phosphodiesterase-4 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Phosphodiesterase-4 Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Phosphodiesterase-4 Inhibitor Sales by Region (2021-2026) & (k units) Table 41. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 42. Global Phosphodiesterase-4 Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 43. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Region (2021-2026) Table 44. Global Phosphodiesterase-4 Inhibitor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Phosphodiesterase-4 Inhibitor Sales by Region (2027-2032) & (k units) Table 46. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 47. Global Phosphodiesterase-4 Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 48. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Region (2027-2032) Table 49. Global Phosphodiesterase-4 Inhibitor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Phosphodiesterase-4 Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 52. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 53. Global Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 54. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application (2021-2026) Table 55. Global Phosphodiesterase-4 Inhibitor Price by Application (2021-2026) & (US$/unit) Table 56. Global Phosphodiesterase-4 Inhibitor Sales by Application (2027-2032) & (k units) Table 57. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 58. Global Phosphodiesterase-4 Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 59. Global Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application (2027-2032) Table 60. Global Phosphodiesterase-4 Inhibitor Price by Application (2027-2032) & (US$/unit) Table 61. North America Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 62. North America Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 64. Europe Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 68. Latin America Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GSK Phosphodiesterase-4 Inhibitor Product Portfolio Table 75. GSK Recent Development Table 76. Fosun-Pharmaceutical Company Information Table 77. Fosun-Pharmaceutical Business Overview Table 78. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product Portfolio Table 80. Fosun-Pharmaceutical Recent Development Table 81. Amgen Company Information Table 82. Amgen Business Overview Table 83. Amgen Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Amgen Phosphodiesterase-4 Inhibitor Product Portfolio Table 85. Amgen Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Phosphodiesterase-4 Inhibitor Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Camber Pharmaceuticals Company Information Table 92. Camber Pharmaceuticals Business Overview Table 93. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product Portfolio Table 95. Camber Pharmaceuticals Recent Development Table 96. Arcutis Biotherapeutics Company Information Table 97. Arcutis Biotherapeutics Business Overview Table 98. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product Portfolio Table 100. Arcutis Biotherapeutics Recent Development Table 101. North America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (k units) Table 103. North America Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026) Table 104. North America Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 106. North America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Phosphodiesterase-4 Inhibitor Market Share by Country (2021-2026) Table 109. North America Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Phosphodiesterase-4 Inhibitor Market Share Forecast by Country (2027-2032) Table 111. Europe Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (k units) Table 113. Europe Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026) Table 114. Europe Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Phosphodiesterase-4 Inhibitor Market Share by Country (2021-2026) Table 119. Europe Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Phosphodiesterase-4 Inhibitor Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Share by Country (2021-2026) Table 129. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Share Forecast by Country (2027-2032) Table 131. Latin America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (k units) Table 133. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026) Table 134. Latin America Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Phosphodiesterase-4 Inhibitor Market Share by Country (2021-2026) Table 139. Latin America Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Phosphodiesterase-4 Inhibitor Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Share by Country (2021-2026) Table 149. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Phosphodiesterase-4 Inhibitor Distributors List Table 154. Phosphodiesterase-4 Inhibitor Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Phosphodiesterase-4 Inhibitor Image Figure 2. Global Phosphodiesterase-4 Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phosphodiesterase-4 Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Phosphodiesterase-4 Inhibitor Sales (2021-2032) & (k units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 7. External Use Image Figure 8. Global External Use Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Phosphodiesterase-4 Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Phosphodiesterase-4 Inhibitor Market Share by Type 2025 VS 2032 Figure 11. North America Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 12. North America Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type in 2025 Figure 13. Europe Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 14. Europe Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Phosphodiesterase-4 Inhibitor Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Phosphodiesterase-4 Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Phosphodiesterase-4 Inhibitor Market Share by Application 2025 VS 2032 Figure 29. North America Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 30. North America Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application in 2025 Figure 31. Europe Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 32. Europe Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. North America Phosphodiesterase-4 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Phosphodiesterase-4 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Phosphodiesterase-4 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Phosphodiesterase-4 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Phosphodiesterase-4 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Phosphodiesterase-4 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Phosphodiesterase-4 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Phosphodiesterase-4 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Phosphodiesterase-4 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Phosphodiesterase-4 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Phosphodiesterase-4 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Phosphodiesterase-4 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Phosphodiesterase-4 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Phosphodiesterase-4 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Phosphodiesterase-4 Inhibitor Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Phosphodiesterase-4 Inhibitor Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • External Use
Applications
  • Children
  • Adults
Companies covered
  • GSK
  • Fosun-Pharmaceutical
  • Amgen
  • AstraZeneca
  • Camber Pharmaceuticals
  • Arcutis Biotherapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phosphodiesterase-4 Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phosphodiesterase-4 Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phosphodiesterase-4 Inhibitor Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 External Use
  8. 1.4 Global Phosphodiesterase-4 Inhibitor Market Size by Type
  9. 1.4.1 Global Phosphodiesterase-4 Inhibitor Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Phosphodiesterase-4 Inhibitor Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Phosphodiesterase-4 Inhibitor Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Phosphodiesterase-4 Inhibitor Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Phosphodiesterase-4 Inhibitor Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Phosphodiesterase-4 Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phosphodiesterase-4 Inhibitor Industry Trends
  2. 2.2 Phosphodiesterase-4 Inhibitor Industry Drivers
  3. 2.3 Phosphodiesterase-4 Inhibitor Industry Opportunities and Challenges
  4. 2.4 Phosphodiesterase-4 Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phosphodiesterase-4 Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by Phosphodiesterase-4 Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by Phosphodiesterase-4 Inhibitor Price (2021-2026)
  4. 3.4 Global Phosphodiesterase-4 Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phosphodiesterase-4 Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global Phosphodiesterase-4 Inhibitor Company, Product Type & Application
  7. 3.7 Global Phosphodiesterase-4 Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phosphodiesterase-4 Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phosphodiesterase-4 Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phosphodiesterase-4 Inhibitor Tier 1, Tier 2, and Tier 3
4 Phosphodiesterase-4 Inhibitor Regional Status and Outlook
  1. 4.1 Global Phosphodiesterase-4 Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phosphodiesterase-4 Inhibitor Historic Market Size by Region
  3. 4.2.1 Global Phosphodiesterase-4 Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phosphodiesterase-4 Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phosphodiesterase-4 Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phosphodiesterase-4 Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global Phosphodiesterase-4 Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phosphodiesterase-4 Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phosphodiesterase-4 Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phosphodiesterase-4 Inhibitor by Application
  1. 5.1 Phosphodiesterase-4 Inhibitor Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Phosphodiesterase-4 Inhibitor Market Size by Application
  5. 5.2.1 Global Phosphodiesterase-4 Inhibitor Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Phosphodiesterase-4 Inhibitor Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Phosphodiesterase-4 Inhibitor Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Phosphodiesterase-4 Inhibitor Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Phosphodiesterase-4 Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Phosphodiesterase-4 Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Phosphodiesterase-4 Inhibitor Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Fosun-Pharmaceutical
  8. 6.2.1 Fosun-Pharmaceutical Company Information
  9. 6.2.2 Fosun-Pharmaceutical Business Overview
  10. 6.2.3 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product Portfolio
  12. 6.2.5 Fosun-Pharmaceutical Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Phosphodiesterase-4 Inhibitor Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Phosphodiesterase-4 Inhibitor Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Camber Pharmaceuticals
  26. 6.5.1 Camber Pharmaceuticals Company Information
  27. 6.5.2 Camber Pharmaceuticals Business Overview
  28. 6.5.3 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product Portfolio
  30. 6.5.5 Camber Pharmaceuticals Recent Developments
  31. 6.6 Arcutis Biotherapeutics
  32. 6.6.1 Arcutis Biotherapeutics Company Information
  33. 6.6.2 Arcutis Biotherapeutics Business Overview
  34. 6.6.3 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product Portfolio
  36. 6.6.5 Arcutis Biotherapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Phosphodiesterase-4 Inhibitor Sales by Country
  2. 7.1.1 North America Phosphodiesterase-4 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phosphodiesterase-4 Inhibitor Market Size by Country
  6. 7.2.1 North America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phosphodiesterase-4 Inhibitor Sales by Country
  2. 8.1.1 Europe Phosphodiesterase-4 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phosphodiesterase-4 Inhibitor Market Size by Country
  6. 8.2.1 Europe Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phosphodiesterase-4 Inhibitor Sales by Country
  2. 10.1.1 South America Phosphodiesterase-4 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phosphodiesterase-4 Inhibitor Market Size by Country
  6. 10.2.1 South America Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phosphodiesterase-4 Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phosphodiesterase-4 Inhibitor Value Chain Analysis
  2. 12.1.1 Phosphodiesterase-4 Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phosphodiesterase-4 Inhibitor Production Mode & Process
  7. 12.2 Phosphodiesterase-4 Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phosphodiesterase-4 Inhibitor Distributors
  10. 12.2.3 Phosphodiesterase-4 Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst